Skip to main content
OpenTrials
Completed

NCT Number: NCT05125887

Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2)

Outpatient management of patients with a milder form of COVID may be associated to an unfavorable initial or deferred course in relation to the pathology.. Outpatients represent the bulk of patients with COVID-19. To know their evolution, their secondary complications and identifying a profile of "at risk" patients is essential for the prevention and care of future non-hospitalized patients, in an epidemic context still active.

This study could make it possible to redefine the follow-up of outpatients. The study consists of a simple questionnaire and possibly a teleconsultation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SARS-CoV2 Infection COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Médecine Interne A

Limoges, 87000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a PCR (polymerase chain reaction assay ) positive for Sars-COV-2 between the start of the pandemic and May 11, 2020
  • Outpatient care
  • Inclusion 24 months from the date of diagnosis of Sars-COV-2 (± 6 months)

Exclusion criteria

  • Patients in EHPAD (accommodation facilities for dependent elderly people), home, retirement home, center for disabled people
  • Patients under protective measure, curators or guardianship
  • Patients with a pathology or condition that does not allow them to express their wishes
  • Patients hospitalized when performing PCR or within 10 days with Sars-COV-2

Treatment and study plan

Questionnaire

Other

Patients diagnosed positive for COVID on an outpatient basis will respond to a questionnaire by mail, at 24 month of diagnosis. This questionnaire will make it possible in particular to collect intercurrent events (hospitalization, emergencies, etc.).

Primary outcomes

  1. Medical procedures

    Time frame: At month 24

    number of medical procedures

Sponsors and collaborators

Lead sponsor

University Hospital, Limoges

Other

Registry information

Official study title

Remote Assessment of Outpatient With SARS-CoV-2

Acronym: EVIDENCE

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Nov 18, 2021
Registry last updated
Jun 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.